[1] Arnold M, Sierra M S, Laversanne M, et al. Global patterns and trends in colorectal cancer incidence and mortality[J]. Gut, 2017, 66(4): 683-691. [2] Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA: A Cancer Journal for Clinicians, 2024, 74(3): 229-263. [3] 丁璐璐, 徐源佑, 陈永胜, 等. 全球结直肠癌流行现状与人类发展指数关系分析[J]. 中国肿瘤, 2025, 34(8): 611-617. DING Lulu, XU Yuanyou, CHEN Yongsheng, et al. Global epidemic status of colorectal cancer and relationship of colorectal cancer burden with the human development index[J]. China Cancer, 2025, 34(8): 611-617. [4] Chapman W C, Hunt S R, Henke L E. Radiotherapy for rectal cancer: how much is enough?[J]. Clinics in Colon and Rectal Surgery, 2024, 37(4): 207-215. [5] Feeney G, Sehgal R, Sheehan M, et al. Neoadjuvant radiotherapy for rectal cancer management[J]. World Journal of Gastroenterology, 2019, 25(33): 4850-4869. [6] Jaffray D A, Knaul F, Baumann M, et al. Harnessing progress in radiotherapy for global cancer control[J]. Nature Cancer, 2023, 4(9): 1228-1238. [7] Samuelian J M, Callister M D, Ashman J B, et al. Reduced acute bowel toxicity in patients treated with Intensity-modulated radiotherapy for rectal cancer[J]. International journal of radiation oncology, biology, physics, 2012, 82(5): 1981-1987. [8] Saglam Y, Bolukbasi Y, Alpan V, et al. Hybrid arc: combining forward IMRT and double arc VMAT in locally advanced rectum cancer[J]. International Journal of Hematology and Oncology, 2019, 29(2): 97-107. [9] Narita Y, Kato T, Takemasa K, et al. Dosimetric impact of simulated changes in large bowel content during proton therapy with simultaneous integrated boost for locally advanced pancreatic cancer[J]. Journal of Applied Clinical Medical Physics, 2021, 22(11): 90-98. [10] Gurjar O P, Arya R, Goyal H. A study on prostate movement and dosimetric variation because of bladder and rectum volumes changes during the course of image-guided radiotherapy in prostate cancer[J]. Prostate International, 2020, 8(2): 91-97. [11] CHEN Zhi, YANG Zhaozhi, WANG Jiazhou, et al. Dosimetric impact of different bladder and rectum filling during prostate cancer radiotherapy[J]. Radiation Oncology, 2016, 11: 103. [12] Arya R, Goyal H, Naik A, et al. A prospective observational study to analyse the influence of bladder and rectal volume changes on prostate radiotherapy using IMRT[J]. Reports of Practical Oncology & Radiotherapy, 2020, 25(3): 312-317. [13] Beaton L, Bandula S, Gaze M N, et al. How rapid advances in imaging are defining the future of precision radiation oncology[J]. British Journal of Cancer, 2019, 120(8): 779-790. [14] Tocco B R, Kishan A U, Ma T M, et al. MR-guided radiotherapy for prostate cancer[J]. Frontiers in Oncology, 2020, 10: 616291. [15] Weiss E, WU Jian, Sleeman W, et al. Clinical evaluation of soft tissue organ boundary visualization on cone-beam computed tomographic imaging[J]. International Journal of Radiation Oncology, Biology, Physics, 2010, 78(3): 929-936. [16] Van Der Horst A, Houweling A C, Van Tienhoven G, et al. Dosimetric effects of anatomical changes during fractionated photon radiation therapy in pancreatic cancer patients[J]. Journal of Applied Clinical Medical Physics, 2017, 18(6): 142-151. [17] Pearson D, Gill S K, Campbell N, et al. Dosimetric and volumetric changes in the rectum and bladder in patients receiving CBCT-guided prostate IMRT: analysis based on daily CBCT dose calculation[J]. Journal of Applied Clinical Medical Physics, 2016, 17(6): 107-117. [18] 李明, 林海磊, 修霞, 等. 膀胱直肠管理对前列腺癌靶区及OAR剂量影响[J]. 中华放射肿瘤学杂志, 2015(6): 644-648. LI Ming, LIN Hailei, XIU Xia, et al. Effects of bladder and rectum management on dose distributions of target and organs at risk in intensity-modulated radiotherapy for prostate cancer[J]. Chinese Journal of Radiation Oncology, 2015(6): 644-648. [19] Godoy Scripes P, Subashi E, Burleson S, et al. Impact of varying air cavity on planning dosimetry for rectum patients treated on a 1.5 T hybrid MR-linac system[J]. Journal of Applied Clinical Medical Physics, 2020, 21(7): 144-152. [20] 吴晓维. 口服造影剂对宫颈癌调强放疗剂量的影响研究[D]. 合肥: 安徽医科大学, 2018. WU Xiaowei. Investigate effect of oral contrast agent on dose distribution for cervical caner with intensity-modulated radiotherapy[D]. Hefei: Anhui Medical University, 2018. [21] Paddick I. A simple scoring ratio to index the conformity of radiosurgical treatment plans. Technical note[J]. Journal of Neurosurgery, 2000, 93(S3): 219-222. [22] Hodapp N.[The ICRU Report 83: prescribing, recording and reporting photon-beam intensity-modulated radiation therapy (IMRT)][J]. Strahlentherapie Und Onkologie, 2012, 188(1): 97-99. [23] LIU Qiang, LIANG Jian, Stanhope C W, et al. The effect of density variation on photon dose calculation and its impact on intensity modulated radiotherapy and stereotactic body radiotherapy[J]. Medical Physics, 2016, 43(10): 5717. [24] Tuğrul T. Investigation of the effect of CT-relative electron density curves on radiotherapy dose calculation[J/OL]. Health Physics, (2025-05-02)[访问日期缺失]. https://pubmed.ncbi.nlm.nih.gov/40314590/. [25] 张建英, 曾昭冲, 孙菁. 体内金属植入物对放疗剂量分布的影响及物理分析[J]. 中国医学物理学杂志, 2005, 22(3): 505-507, 510. ZHANG Jianying, ZENG Zhaochong, SUN Jing. Dose perturbation of metal objects in patients and a study for the physical causation[J]. Chinese Journal of Medical Physics, 2005, 22(3): 505-507, 510. [26] LI X A, YU C, Holmes T. A systematic evaluation of air cavity dose perturbation in megavoltage x-ray beams[J]. Medical Physics, 2000, 27(5): 1011-1017. |